Richard Aplenc MD, PhD
Associate Professor of Pediatrics
Richard is an associate professor of pediatrics in the Department of Pediatrics, and a member of the Center for Pediatric Clinical Effectiveness and DBHi at CHOP. His research focuses on improving the outcomes of children with cancer, particularly acute myeloid leukemia (AML) and involves molecular epidemiology, pediatric cancer Phase I clinical trials, treatment of pediatric AML, and the use of genetic polymorphism data to predict treatment response to therapeutic interventions, particularly in pediatric cancer therapy. He is currently leading a genome-wide genotyping effort to discover genetic variations that change the risks of relapse, life-threatening infections, and heart complications in children treated for AML. He also leads several efforts to use administrative data sets to improve the care of children with AML, particularly focusing on antibiotic and intensive care use. Richard received his MD from the University of Virginia School of Medicine and his MSCE and PhD from the University of Pennsylvania.